The landscape of modern medical aesthetics in the United Kingdom continues to experience rapid evolution, driven by an increasing consumer demand for clinically proven formulations and physician-led treatments. In a significant development for the luxury skincare sector, renowned cosmeceutical brand iS Clinical has officially announced a new retail and clinical partnership with ALTA Medi, a prominent doctor-led medical aesthetics clinic situated in the heart of London’s prestigious Marylebone district.
This collaboration brings together a globally recognized leader in science-driven topical skincare and a boutique London clinic recognized for its bespoke, patient-centric approach to aesthetic medicine. As part of the rollout, ALTA Medi will integrate iS Clinical’s extensive professional and retail product lines into its daily operations. Most notably, the clinic will now offer the brand’s flagship signature treatment, the Fire & Ice Resurfacing Facial, bridging the gap between advanced clinical efficacy and luxury spa-grade relaxation.
The partnership represents a calculated expansion for iS Clinical within the competitive UK market, while simultaneously equipping ALTA Medi with a clinically validated skincare portfolio designed to complement its existing suite of advanced dermatological and aesthetic procedures.
Background and Context of the Collaboration
Founded by aesthetic practitioner and medical professional Anastasia Koles, ALTA Medi has built a reputation in central London for its rigorous, medically informed methodologies. Operating out of Marylebone—an area globally synonymous with high-end wellness, Harley Street medical practices, and luxury healthcare—the clinic prioritizes personalized aesthetic journeys over standardized, one-size-fits-all treatments. The philosophy centers on empowering patients through tailored transformations that respect the biological integrity of the skin.
Conversely, iS Clinical, distributed in the UK through Harpar Grace International, is celebrated globally for its commitment to botanical-pharmaceutical science. The brand invests heavily in independent clinical research to substantiate the efficacy of its formulations, which target a wide array of dermatological concerns, including hyperpigmentation, acne, rosacea, and signs of intrinsic aging.
In recent years, the intersection of clinical dermatology and medical aesthetics has become the fastest-growing segment of the beauty industry. Consumers are increasingly turning away from superficial cosmetic fixes in favor of long-term skin health strategies supported by active ingredients such as pharmaceutical-grade L-ascorbic acid, botanical antioxidants, and pharmaceutical-grade retinols. The alignment between iS Clinical and ALTA Medi capitalizes on this macro-trend, offering patients a seamless continuum of care from in-clinic procedural interventions to at-home maintenance regimens.
Chronology and Integration of Services
The partnership is the culmination of months of strategic planning and alignment between the executive leadership at Harpar Grace International and the clinical team at ALTA Medi. Discussions began in early 2024, focusing on shared values regarding patient safety, ethical practice, and demonstrable clinical outcomes.
Following the finalization of the agreement, the official integration commenced with comprehensive staff training protocols. Clinicians and skin therapists at ALTA Medi underwent rigorous education led by iS Clinical’s medical training division to master the precise application techniques required for the brand’s professional peels and specialized protocols.
At the core of this service integration is the introduction of the Fire & Ice Resurfacing Facial. Often referred to in the industry as the "Red Carpet Facial," this intensive treatment is designed to safely resurface the skin, reduce fine lines, address cellular renewal, and smooth textural irregularities. The multi-step protocol utilizes two therapeutic masques—the intensive resurfacing masque containing pharmaceutical-grade glycolic acid, citric acid, malic acid, retinol, niacinamide, and potent antioxidants, followed by a rejuvenating, soothing masque formulated with hyaluronic acid, aloe vera, green tea extracts, and rosemary.
By incorporating this treatment alongside the brand’s targeted serums—such as the globally acclaimed Active Serum and Pro-Heal Serum Advance+—ALTA Medi aims to enhance the efficacy of its existing clinical offerings, which include advanced injectables, skin-resurfacing lasers, and medical-grade microneedling.
Official Statements from Leadership
The announcement has garnered significant attention within the British aesthetics community, drawing official commentary from the leadership teams of both organizations.
Erica Casey, Chief Executive Officer of Harpar Grace International—the exclusive UK distributor for iS Clinical—underscored the strategic importance of the collaboration.
"We are delighted to welcome ALTA Medi into the iS Clinical family," stated Casey. "Their aesthetic excellence and mission to empower patients through tailored, bespoke transformation, make them an ideal partner as we continue to grow iS Clinical’s presence across the UK. Marylebone is a vital hub for advanced aesthetics, and aligning with a clinic of this caliber ensures our formulations are placed in the hands of practitioners who truly understand the science of skin health."
Echoing these sentiments, Anastasia Koles, Founder and Lead Clinician at ALTA Medi, highlighted the philosophical and scientific synergy driving the partnership.
"We chose to partner with iS Clinical because their science-driven approach to skincare aligns perfectly with our clinic’s values and delivers the clear, visible results our patients expect," Koles remarked. "Our mission is to elevate beauty and wellness standards through innovation, expertise, and compassion—and iS Clinical is the ideal partner to help us offer that trusted, elevated experience to our discerning clientele."
Supporting Data and Industry Trends
To understand the broader implications of this partnership, industry analysts look to the steady growth of the UK medical aesthetics market. According to recent market research data, the UK non-surgical aesthetic treatment sector is valued at over £3 billion, with cosmeceuticals and clinically backed skincare representing a rapidly expanding share of consumer spending.
Consumer habits have shifted dramatically over the past half-decade. Post-pandemic wellness trends have accelerated the "skin-first" movement, wherein consumers prioritize skin barrier health and preventative care over heavy makeup or invasive surgical procedures. Clinical skincare brands that can demonstrate rigorous third-party testing and peer-reviewed safety data are increasingly capturing market share from traditional department store beauty counters.
Furthermore, geographic clustering in districts like Marylebone and neighboring Harley Street has intensified competition among aesthetic clinics. To stand out, boutique clinics must offer exclusive, high-performance product lines that cannot be acquired via mass-market e-commerce platforms. By securing exclusive access to professional-grade iS Clinical protocols, ALTA Medi strengthens its competitive advantage within London’s saturated luxury wellness market.
Broader Impact and Market Implications
The collaboration between iS Clinical and ALTA Medi serves as a case study for the modern distribution model in medical aesthetics. Successful brands no longer rely solely on widespread retail availability; instead, they cultivate strategic partnerships with high-end, doctor-led clinics where consumer education and clinical oversight are prioritized.
For patients visiting ALTA Medi, the partnership guarantees access to authenticated, medical-grade products backed by clinical data, mitigating the rising risks associated with counterfeit or diverted skincare products sold through unauthorized online channels. It also establishes a clear pathway for longitudinal skin health tracking, where practitioners can monitor patient progress through a combination of in-clinic treatments and customized home-care prescriptions.
As this partnership rolls out across the clinic’s Marylebone location, industry observers will be watching closely to see how similar collaborations shape the future of urban aesthetic practices in the United Kingdom. With consumer expectations higher than ever, the convergence of advanced clinical formulations and bespoke medical expertise appears poised to remain the gold standard for luxury skincare and aesthetic medicine in the years to come.
